A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

Clinical trial NCT05775523 · RECRUITING

Trial details

NCT number: NCT05775523
Sponsor: Ascendis Pharma Endocrinology Division A/S
Status: RECRUITING
Study type: OBSERVATIONAL

Growth Hormone Deficiency

Start date: 2023-03-20
Primary completion: 2033-03-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.